<DOC>
	<DOCNO>NCT00969371</DOCNO>
	<brief_summary>The purpose follow clinical protocol evaluate safety effectiveness Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens ( IOL ) protocol inclusion/exclusion criterion .</brief_summary>
	<brief_title>Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens ( IOL ) Clinical Investigation</brief_title>
	<detailed_description>The Lenstec TetraFlex Accommodating Posterior Chamber Intraocular Lens ( IOL ) ultraviolet absorb optical implant design replacement human crystalline lens follow phacoemulsification cataract removal . The TetraFlex Accommodating Posterior Chamber IOL design treatment aphakia . The lens indicate primary implantation cataractous lens remove phacoemulsification circular tear capsulotomy posterior capsule intact . The intended benefit TetraFlex Accommodating Posterior Chamber IOL provide enhance distance near vision increase independence corrective lens wear .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Male Female Any race Patients age time surgery 18 year old . Presence bilateral cataract require cataract extraction . If one eye implant study lens , eye may cataract extraction IOL implantation . Clear intraocular medium cataract . Patients BSCVA &lt; 20/40 cataract glare acuity bad 20/30 Corneal Astigmatism le 1 Diopter . Good Visual Potential : Best correct visual acuity ( BCVA ) project PAM Pinhole 20/25 good pathology suspect . Patient able willing comply followup . Able provide write informed consent . Patients monocular . Presence ocular infection . Greater equal 1 Diopter preoperative corneal astigmatism . Patients antipsychotic antidepressant medication could potentially effect accommodation Patients chronically take medication may affect accommodation , include first generation antihistamine , anticholinergic agent . Previous intraocular surgery either eye . Previous serious corneal disease . Diagnosis follow ocular condition : active scleral disease , glaucoma , retinal disease potentially affecting central vision , macular disease uveitis , severe dry eye dysthyroid eye disease Subjects may expect require retinal laser treatment . Subjects diagnose degenerative visual disorder ( e.g . macular degeneration retinal disorder ) predict cause future acuity loss level 20/30 bad ) . Patients require administration topical ophthalmic medication study medication . Use systemic corticosteroid antimetabolite medication could affect wound heal specifically contraindicate . Allergy anesthetic postoperative medication . Presence uncontrolled systemic disease ( e.g . diabetes , hypertension , cardiovascular disease ) . Pregnant lactate woman Persons , determination investigator , competent understand procedure , action ask research subject , capable complete patient satisfaction questionnaire . Participation previous clinical trial within 30 day prior start study . Persons may able complete requirement return investigator 's clinic period study , may difficult locate contact short notice . This preclude vacation travel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>posterior chamber intraocular lens</keyword>
	<keyword>PCIOL</keyword>
	<keyword>IOL</keyword>
</DOC>